about
Data quality in an information-rich environment: Canada as an example.Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low- and middle-income countriesChildhood Cancer Mortality in India: Direct Estimates From a Nationally Representative Survey of Childhood Deaths.The Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer.Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia.Low socioeconomic status is associated with worse survival in children with cancer: a systematic reviewPaediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines.The validity of pediatric cancer diagnoses in a population-based general cancer registry in Ontario, Canada.The Validity of Using Health Administrative Data To Identify the Involvement of Specialized Pediatric Palliative Care Teams in Children with Cancer in Ontario, Canada.Breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin.Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador.Identification of educational and infrastructural barriers to prompt antibiotic delivery in febrile neutropenia: a quality improvement initiative.Pediatric oncology research in low income countries: ethical concepts and challenges.The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi.The expanding role of primary care in cancer control.Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition.Validity of Administrative Data in Identifying Cancer-related Events in Adolescents and Young Adults: A Population-based Study Using the IMPACT Cohort.Optimizing medication adherence in children with cancer.Evaluation of the need for chest X-rays in the management of asymptomatic, intraluminal vascular access device occlusion in childhood cancer.Predictors of diagnostic interval and associations with outcome in acute lymphoblastic leukemia.Predictors of hospital readmission of Manitoba newborns within six weeks postbirth discharge: a population-based study.Microbiology and mortality of pediatric febrile neutropenia in El Salvador.Anaplastic Large Cell Lymphoma in Central America: A Report From the Central American Association of Pediatric Hematology Oncology (AHOPCA).Treatment of young children with CNS-positive acute lymphoblastic leukemia without cranial radiotherapy.The cost and cost-effectiveness of childhood cancer treatment in El Salvador, Central America: A report from the Childhood Cancer 2030 Network.Impact of Ethnicity on Donor Search Results for Children Requiring Stem Cell Transplantation.Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador.Future cancer research priorities in the USA: a Lancet Oncology Commission.The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma.Use of Anesthesia for Imaging Studies and Interventional Procedures in Children.Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study.Improving childhood cancer care in Latin America and the Caribbean: a PAHO Childhood Cancer Working Group position statement.Development of Quality Metrics to Evaluate Pediatric Hematologic Oncology Care in the Outpatient Setting.Predictors of Specialized Pediatric Palliative Care Involvement and Impact on Patterns of End-of-Life Care in Children With Cancer.Socioeconomic determinants of mortality in two Canadian provinces: multilevel modelling and neighborhood context.Adverse mental health outcomes in a population-based cohort of survivors of childhood cancer.Socioeconomic status and event free survival in pediatric acute lymphoblastic leukemia: a population-based cohort study.Blastomycosis infection in an adolescent patient with Hodgkin lymphoma.Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia.The utility of end-of-treatment bone marrow aspirates in pediatric acute lymphoblastic leukemia: a quality improvement project.
P50
Q30998314-A2933DA8-3587-48CB-B0FC-74FFEA8D9845Q33768839-D1362728-8A16-47F1-AF19-598124A71B81Q33859612-DCD1EA56-355C-448E-9306-62EAD04AA369Q34491288-9E14BCC4-CFE8-4F21-9BD4-CB13C4FB0F29Q34747454-DCAAD405-6EA8-4BD5-BCD5-DA3CABCAEDD3Q35107431-454D5D3B-A89F-4DE8-8142-48E3B6D2B7BEQ36051934-1A80E29F-7E15-459E-B4A1-3463E273068FQ36191920-0A7FD957-FA28-4406-9495-AD1B899C3ED5Q36396069-4AB54874-4436-4E89-A370-9D50C6550C5BQ36684261-82C1D73E-134E-4467-AEDA-D542405FAE6AQ37160666-4C7CBF4E-84E1-4A61-84BB-DDE4451F80C8Q37965480-51B58E4F-13F1-475B-B098-47853AC1B5B4Q37965483-436C252E-25F4-45D2-831B-A1BA3B8B54BAQ38412219-13930CE4-CF24-40BF-966F-D5EDE0BDEC88Q38598014-337FBB0D-FCB4-4DBA-AC2B-769327F16331Q38636398-E4F715B6-FDEE-47BA-A668-C4ACAD0D9BC8Q38668033-3B97D494-32E5-4B89-BBC9-BB540F8FC445Q38801931-DBB18761-8D80-4CB9-83F4-3E16CDE12BD4Q39037262-29A4B31B-CBE3-47C3-95C5-C62FFCD7CB8DQ39059553-594A097C-FE51-4025-ACDB-7E07827ED25BQ39693564-A300447C-3B08-446E-8A90-1D28CF2A6698Q40327081-50C7811F-D31A-41D0-B99B-627C9B0B7405Q40643182-6B62E68A-CD9A-4DF5-8C0C-94CA0CA9C968Q41603185-DBE74D1A-B260-485F-B6E2-CF2F84639E0AQ42690896-0453BF52-C665-4E62-A873-75D5CC2ED302Q45082677-387E9263-7B41-474F-9E4F-23E12894543DQ46033442-A501D3F3-897B-41E7-B8AD-D888765FBCE4Q46160844-5B68273D-FE82-4AD3-9631-F1D67B385E33Q46497526-72E0C91C-6CC9-46F9-9C8C-1857779B28AEQ47394643-833E50F9-297D-4BF4-8C1A-86D578EEB0D1Q47587707-C5D12064-9562-4D25-9C66-52221FE35960Q47700089-B2FDBBF1-93FE-43EE-9E4A-F7E7C682EE99Q47729954-0D5905D5-C198-4361-96B7-58B4724B0D41Q50111113-8D756B6F-3D40-40B1-AB34-B728FD1DA874Q50145302-9A88FD42-A65C-42ED-8C50-2D8D62F6A168Q52315673-302C057B-94BB-4948-89B6-C2F51EF7D532Q53019735-342B62F1-1E4D-42A2-A7A0-5F1A495AD07DQ53708852-572543EB-4767-4979-9729-E3E523AD78C7Q54291837-7BA6CD2F-1B09-4FEA-A75C-1DFBC5221596Q54308644-D050E74B-BAA0-4629-ABE1-E7D0C509B329
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sumit Gupta
@ast
Sumit Gupta
@en
Sumit Gupta
@es
Sumit Gupta
@nl
Sumit Gupta
@sl
type
label
Sumit Gupta
@ast
Sumit Gupta
@en
Sumit Gupta
@es
Sumit Gupta
@nl
Sumit Gupta
@sl
prefLabel
Sumit Gupta
@ast
Sumit Gupta
@en
Sumit Gupta
@es
Sumit Gupta
@nl
Sumit Gupta
@sl
P108
P106
P31
P496
0000-0003-1334-3670